J. Howlett

发表

HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations.

S. Priori, P. Vardas, J. Brugada, 2008, Heart rhythm.

Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children.

Alexander G Logan, Simon L Bacon, Michael D Hill, 2018, The Canadian journal of cardiology.

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2013, The Canadian journal of cardiology.

Cardiac remodelling predicts outcome in patients with chronic heart failure

Richard B. Thompson, James A. White, J. Dyck, 2021, ESC heart failure.

The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Paul Stolee, Anthony M Herd, Peter Liu, 2010, The Canadian journal of cardiology.

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction

Richard B. Thompson, James A. White, J. Dyck, 2020, ESC heart failure.

HFSA 2006 comprehensive heart failure practice guideline

Prakash Deedwania, John Boehmer, J. H. Patterson, 2006 .

Executive Summary Executive Summary : HFSA 2010 Comprehensive Heart Failure Practice Guideline

J. H. Patterson, Randall C. Starling, Prakash C. Deedwania, 2022 .

Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial.

S. Solomon, R. Diaz, J. McMurray, 2021, JAMA cardiology.

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials

P. Ponikowski, S. Solomon, A. Parkhomenko, 2020, European journal of heart failure.

What's New Heart Failure?

J. Howlett, R. Townley, 2002 .

Computerized Electronic Order Set: Use and Outcomes for Heart Failure Following Hospitalization

J. Howlett, Robert J. H. Miller, J. Eisner, 2020, CJC open.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2013, The Canadian journal of cardiology.

Palliative care in heart failure: addressing the largest care gap

J. Howlett, 2011, Current opinion in cardiology.

A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)

Akshay S. Desai, D. DeMets, P. Ponikowski, 2019, European journal of heart failure.

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

Akshay S. Desai, D. DeMets, P. Ponikowski, 2019, The New England journal of medicine.

Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].

J. Rouleau, D. Prabhakaran, R. Favaloro, 2014, Journal of the American College of Cardiology.

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.

R. McKelvie, H. Abrams, A. Cohen-Solal, 2020, The Canadian journal of cardiology.

The promise of patient‐reported outcomes: one step closer to routine care

J. Howlett, 2018, European journal of heart failure.

Does heart rate really matter to patients with heart failure?

J. Howlett, Robert J. H. Miller, 2016, Current opinion in cardiology.

Hospitalization for acute heart failure syndromes.

J. Howlett, M. Slawnych, J. Simon, 2011, JAMA.

Ivabradine in Heart Failure: The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure

L. Lund, M. Fu, U. Dahlström, 2017, Circulation. Heart failure.

Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction

Akshay S. Desai, D. DeMets, P. Ponikowski, 2020, Circulation.

Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study.

F. McAlister, N. Fine, J. Ezekowitz, 2019, European heart journal.

2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation.

M. Carrier, P. Hendry, A. Menkis, 2003, The Canadian journal of cardiology.

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.

R. McKelvie, A. Cohen-Solal, A. Ducharme, 2021, The Canadian journal of cardiology.

A Novel Approach to Medical Management of Heart Failure with Reduced Ejection Fraction.

N. Fine, J. Howlett, Robert J. H. Miller, 2021, The Canadian journal of cardiology.

The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure.

S. Yusuf, R. McKelvie, J. Rouleau, 2003, The Canadian journal of cardiology.

Advance care planning: identifying system-specific barriers and facilitators.

J. Holroyd-Leduc, J. Howlett, N. Hagen, 2015, Current oncology.

Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.

J. Légaré, J. Sapp, J. Howlett, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

RS/EHRA Expert Consensus on the Monitoring of Cardiovascular mplantable Electronic Devices (CIEDs): Description of Techniques, ndications, Personnel, Frequency and Ethical Considerations

S. Priori, P. Vardas, J. Brugada, 2008 .

Treatment of diabetes in people with heart failure.

J. Howlett, J. MacFadyen, 2013, Canadian journal of diabetes.

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction.

Akshay S. Desai, P. Ponikowski, S. Solomon, 2021, JACC. Heart failure.

A qualitative study of the current state of heart failure community care in Canada: what can we learn for the future?

N. Giannetti, K. Harkness, J. Howlett, 2015, BMC Health Services Research.

A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: the impact of beta-blockade.

C. Josephson, J. Howlett, J. Finley, 2006, The Canadian journal of cardiology.

CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial.

I. Piña, M. Drazner, P. Jhund, 2019, JACC. Heart failure.

Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial

R. McKelvie, R. Doughty, F. McAlister, 2022, The Lancet.

Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

D. DeMets, S. Solomon, J. McMurray, 2020, Circulation.

The Need for Heart Failure Advocacy in Canada.

A. Ducharme, Jillianne Code, H. Ross, 2017, The Canadian journal of cardiology.

Should we perform a heart failure risk score?

J. Howlett, 2013, Circulation. Heart failure.

Relation of Depression to Severity of Illness in Heart Failure (From HF-ACTION [Heart Failure and a Controlled Trial Investigating Outcomes of Exercise)] Training)

P. Binkley, Fletcher, W. Kop, 2009 .

Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.

A. Ducharme, N. Fine, D. Reece, 2020, The Canadian journal of cardiology.

Determinants and Prognostic Significance of Serial Right Heart Function Changes in Patients With Cardiac Amyloidosis.

James A. White, N. Fine, J. White, 2020, The Canadian journal of cardiology.

Evidence of increasing public participation in advance care planning: a comparison of polls in Alberta between 2007 and 2013

D. Heyland, J. Holroyd-Leduc, J. Howlett, 2016, BMJ Supportive & Palliative Care.

Performance feedback: a common thread in the process to provide optimal heart failure care.

J. Howlett, 2009, Journal of the American College of Cardiology.

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

R. McKelvie, H. Abrams, A. Ducharme, 2015, The Canadian journal of cardiology.

Benefit of Neoral C2 Monitoring in De Novo Cardiac Transplant Recipients Receiving Basiliximab Induction

H. Ross, J. Howlett, L. Straatman, 2008, Transplantation.

Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.

A. Ignaszewski, H. Ross, M. White, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial

S. Solomon, R. Diaz, J. McMurray, 2022, European heart journal.

Response to The J-Point Revisited

S. Solomon, M. Pfeffer, R. Califf, 2008 .

The International EMB Position Paper: A basis for integration into modern clinical practice.

M. Crespo-Leiro, J. Howlett, 2021, Journal of cardiac failure.

Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster Analysis.

F. McAlister, J. Dyck, J. Ezekowitz, 2022, Current problems in cardiology.

Untying the Gordian knot of sex and heart failure therapy

J. Howlett, Robert J. H. Miller, 2021, European journal of heart failure.

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction".

J. Howlett, 2021, The Canadian journal of cardiology.

The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey

R. McKelvie, H. Abrams, A. Cohen-Solal, 2020, CJC open.

Differentiating heart failure phenotypes using sex‐specific transcriptomic and proteomic biomarker panels

B. McManus, R. Ng, J. Dyck, 2017, ESC heart failure.

Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination.

I. Piña, C. Yancy, P. Armstrong, 2001, Congestive heart failure.

Abstract 9925: Association between Resting Heart Rate, Chronotropic Index and Long-term Outcomes in Patients with Heart Failure Receiving Beta-blocker Therapy. Data from the HF-ACTION Trial

W. Kraus, S. Keteyian, S. Stevens, 2012 .

Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis.

James A. White, N. Fine, J. White, 2019, Journal of cardiac failure.

Low Prevalence of Transcatheter Mitral Valve Repair Eligibility in a Community Heart Failure Population.

F. McAlister, N. Fine, J. Ezekowitz, 2020, Circulation. Heart failure.

Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial).

C. O'connor, K. Dickstein, J. McMurray, 2016, The American journal of cardiology.

N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study Heart Failure

G. Moe, J. Howlett, H. Zowall, 2007 .

Randomized, Placebo-Controlled Trial of the Angiotensin Receptor Antagonist Losartan for Posttraumatic Stress Disorder

Charles T. Taylor, K. Ressler, M. Stein, 2021, Biological Psychiatry.

Expert Consensus on the Monitoring of Cardiovascular mplantable Electronic Devices ( CIEDs ) : Description of Techniques , ndications , Personnel , Frequency and Ethical Considerations eveloped in partnership with the Heart

S. Priori, P. Vardas, J. Brugada, 2008 .

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.

Akshay S. Desai, P. Ponikowski, S. Solomon, 2020, JAMA.

Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients

James A. White, N. Fine, J. White, 2022, BMC Cardiovascular Disorders.

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

R. McKelvie, K. Teo, J. Arnold, 2006, The Canadian journal of cardiology.

I have heart failure - what happens now, Doc?

J. Howlett, 2009, The Canadian journal of cardiology.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2012, The Canadian journal of cardiology.

Study'' Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Testing Improves the Management of Patients With Suspected Acute Heart Failure: B-Type Natriuretic Peptide - Response to Letter Regarding Article, ''N-Terminal Pro

J. Januzzi, G. Moe, J. Howlett, 2012 .

Response to Letter Regarding Article, "N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized

J. Januzzi, G. Moe, J. Howlett, 2008 .

Can Machines Find the Sweet Spot in End-Stage Heart Failure?

J. Howlett, Robert J. H. Miller, D. Chew, 2022, JACC: Advances.

External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.

F. McAlister, J. Dyck, J. Ezekowitz, 2019, Circulation.

Dancing Cats, Heart Failure, and Circulating Troponin.

J. Howlett, 2019, Journal of cardiac failure.

A Case of Palpitations Due to T-Wave Oversensing Caused by Sacubitril/Valsartan.

J. Howlett, N. Sharma, V. Kuriachan, 2018, The Canadian journal of cardiology.

Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review

J. Howlett, J. Storek, J. Weatherald, 2022, Cells.

Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction

S. Solomon, M. Pfeffer, R. Califf, 2008, Hypertension.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2007, The Canadian journal of cardiology.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2010, The Canadian journal of cardiology.

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.

P. McFarlane, E. Schiffrin, A. Logan, 2016, The Canadian journal of cardiology.

Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure.

T. Mcconnell, I. Piña, Lawrence J. Fine, 2012, American heart journal.

Integration of monitoring technology for heart failure

B. Clarke, J. Howlett, 2012, Current opinion in cardiology.

The Changing Landscape – Palliative Care in the Heart Failure Patient Population

J. Howlett, M. Slawnych, J. Simon, 2012 .

The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure.

S. Yusuf, R. McKelvie, J. Rouleau, 2001, The Canadian journal of cardiology.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2008, The Canadian journal of cardiology.

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.

R. McKelvie, H. Abrams, A. Cohen-Solal, 2017, The Canadian journal of cardiology.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Simon L Bacon, Michael D Hill, Pierre Larochelle, 2014, The Canadian journal of cardiology.

HFSA 2006 Comprehensive Heart Failure Practice Guideline HFSA 2006 Comprehensive Heart Failure Practice Guideline

D. Baker, M. Gheorghiade, B. Massie, 2006 .

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

R. McKelvie, A. Ducharme, M. Gardner, 2008, The Canadian journal of cardiology.

Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease.

J. Howlett, 2014, The Canadian journal of cardiology.

Factors Associated With 7-Day Rehospitalization After Heart Failure Admission

C. Eastwood, H. Quan, K. King-Shier, 2017, The Journal of cardiovascular nursing.

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.

R. McKelvie, A. Ducharme, J. Floras, 2011, The Canadian journal of cardiology.

Canadian Consensus on cardiac transplantation in pediatric and adult congenital heart disease patients 2004: executive summary.

A. Marelli, N. Giannetti, N. Poirier, 2005, The Canadian journal of cardiology.

Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction

J. Howlett, 2008, Expert review of cardiovascular therapy.

Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.

N. Giannetti, S. Busque, A. Ignaszewski, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Acute heart failure: lessons learned so far.

J. Howlett, 2011, The Canadian journal of cardiology.

Current treatment options for early management in acute decompensated heart failure.

J. Howlett, 2008, The Canadian journal of cardiology.

Treating the right patient at the right time: access to heart failure care.

J. Brophy, J. Arnold, H. Ross, 2006, The Canadian journal of cardiology.

Effects of dapagliflozin in DAPA-HF according to background heart failure therapy

Akshay S. Desai, D. DeMets, P. Ponikowski, 2020, European heart journal.

Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms.

M. Pfeffer, K. Swedberg, J. Tardif, 2015, The Canadian journal of cardiology.

Retrospective review of in hospital use of mineralocorticoid receptor antagonists for high risk patients following myocardial infarction

J. Howlett, Robert J. H. Miller, 2015, BMC Cardiovascular Disorders.

Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysis.

D. Exner, S. Wilton, J. Howlett, 2015, The Canadian journal of cardiology.

Evolving role for mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction

J. Howlett, Robert J. H. Miller, 2015, Current opinion in cardiology.

The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.

R. McKelvie, A. Ducharme, V. Rao, 2013, The Canadian journal of cardiology.

Society Guidelines The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure

R. McKelvie, A. Ducharme, V. Rao, 2013 .

Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registry.

J. Cox, J. Howlett, D. Johnstone, 2009, The Canadian journal of cardiology.

The effect of spironolactone use on heart failure mortality: a population-based study.

J. Cox, Ansar Hassan, J. Howlett, 2007, Journal of cardiac failure.

Clinical Investigations The Effect of Spironolactone Use on Heart Failure Mortality: A Population-Based Study

J. Cox, Ansar Hassan, Nova Scotia, 2007 .

Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

R. McKelvie, A. Ducharme, V. Rao, 2007, The Canadian journal of cardiology.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Simon L Bacon, Martin G Myers, Michael D Hill, 2011, The Canadian journal of cardiology.

The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

S. Solomon, M. Pfeffer, R. Califf, 2006, Journal of the American College of Cardiology.

N-Terminal Pro–B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study

J. Januzzi, G. Moe, J. Howlett, 2007, Circulation.

Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2017, The Canadian journal of cardiology.

Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial: Findings From the Acute Study Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)

R. Califf, R. Diaz, C. O'connor, 2013, Circulation. Cardiovascular quality and outcomes.

HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)

Silvia G Priori, Angelo Auricchio, Josep Brugada, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Personalized care of patients with heart failure: are we ready for a REWOLUTION? Insights from two international surveys on healthcare professionals' needs and patients' perceptions

L. Lund, M. Komajda, F. Zannad, 2023, European journal of heart failure.

Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes?

Jean-Claude Tardif, E. Lonn, J. Tardif, 2008, The Canadian journal of cardiology.

The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis.

F. McAlister, P. Kaul, A. Ohinmaa, 2016, CMAJ open.

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes.

Akshay S. Desai, P. Ponikowski, G. Filippatos, 2020, European heart journal.

Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.

P. Ponikowski, S. Solomon, A. Parkhomenko, 2020, The New England journal of medicine.

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial.

W. Kraus, S. Keteyian, I. Piña, 2009, JAMA.

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

R. McKelvie, A. Ducharme, J. Arnold, 2009, The Canadian journal of cardiology.

The time has finally come to prioritize drug initiation before dose titration for patients with heart failure and reduced ejection fraction

J. Howlett, 2020, European journal of heart failure.

Cost-Effectiveness of Earlier Transition to Angiotensin Receptor Neprilysin Inhibitor in Patients With Heart Failure and Reduced Ejection Fraction

J. Howlett, A. Grant, Robert J. H. Miller, 2020, CJC open.

Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation

D. Southern, S. Wilton, M. Knudtson, 2016, Open Heart.

Cost‐effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure

J. McMurray, N. Fine, P. McEwan, 2023, European journal of heart failure.

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial.

Stephen Gottlieb, Steven Keteyian, Christopher O'Connor, 2012, JAMA.

The relationship of quality of life, depression, and caregiver burden in outpatients with congestive heart failure.

J. Howlett, G. Butler, Peter Hooley, 2005, Congestive heart failure.

Quality-of-Life Outcomes With Coronary Artery Bypass Graft Surgery in Ischemic Left Ventricular Dysfunction

K. Anstrom, D. Mark, J. Spertus, 2014, Annals of Internal Medicine.

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.

R. McKelvie, A. Ducharme, V. Rao, 2014, The Canadian journal of cardiology.

Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial.

K. Anstrom, D. Mark, J. Spertus, 2009, American heart journal.

Prospective evaluation of nocturnal oximetry for detection of sleep-related breathing disturbances in patients with chronic heart failure.

Alexander G Logan, T Douglas Bradley, A. Logan, 2005, Chest.

Acutely decompensated congestive heart failure: new therapies for an old problem

J. Howlett, 2005, Expert review of cardiovascular therapy.

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.

R. McKelvie, H. Abrams, A. Ducharme, 2016, The Canadian journal of cardiology.

Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.

Lawrence A Leiter, P. McFarlane, E. Schiffrin, 2020, The Canadian journal of cardiology.

Exercise Capacity and Cardiovascular Adaptations to Aerobic Training Early After Stroke

M. MacKay-Lyons, J. Howlett, 2005, Topics in stroke rehabilitation.

Heart failure guidelines fail

J. Ezekowitz, J. Howlett, E. O’Meara, 2015, Canadian Medical Association Journal.

End-of-life planning in heart failure: it should be the end of the beginning.

M. Fortin, J. Shamian, N. Suskin, 2010, The Canadian journal of cardiology.

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure

Akshay S. Desai, G. Filippatos, J. Butler, 2019, European journal of heart failure.

Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index

P. Ponikowski, J. McMurray, M. Sabatine, 2021, European journal of heart failure.

CARDIOVASCULAR CO-MORBIDITIES AND FIVE YEAR SURVIVAL IN A LARGE CONTEMPORARY OUTPATIENT COHORT OF PATIENTS WITH CHRONIC HEART FAILURE

G. Marchiori, J. Arnold, A. Kaan, 2012 .

Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.

J. Cox, I. Sketris, J. Howlett, 2003, The Canadian journal of cardiology.

Prognostic Value of Right Ventricular Strain Using Speckle-Tracking Echocardiography in Pulmonary Hypertension: A Systematic Review and Meta-analysis.

Jeroen J. Bax, James A. White, James D. Thomas, 2018, The Canadian journal of cardiology.

Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure

W. Kraus, S. Keteyian, G. Blackburn, 2012 .

Specialist heart failure clinics must evolve to stay relevant.

J. Howlett, 2014, The Canadian journal of cardiology.

Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION]).

C. O'connor, P. Binkley, W. Kop, 2009, The American journal of cardiology.

The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study

Richard B. Thompson, I. Belenkie, F. McAlister, 2014, BMC Cardiovascular Disorders.

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)

D. DeMets, P. Ponikowski, S. Solomon, 2020, European heart journal.

Metabolic Syndrome and Its Components in Individuals Undergoing Rehabilitation After Stroke

M. MacKay-Lyons, J. Howlett, C. MacDonald, 2009, Journal of neurologic physical therapy : JNPT.

Current state of cardiac amyloidosis

J. Howlett, N. Sharma, 2013, Current opinion in cardiology.

Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.

W. Kraus, S. Keteyian, F. Zannad, 2013, European heart journal.

Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study

M. James, S. Wilton, M. Knudtson, 2018, Canadian journal of kidney health and disease.

Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.

R. Califf, C. O'connor, J. Rouleau, 2013, JACC. Heart failure.

Canadian Cardiovascular Society - Canadian Heart Failure Society Focused Clinical Practice Update of Patients with Differing Heart Failure Phenotypes.

A. Ducharme, J. Andrade, J. Ezekowitz, 2023, The Canadian journal of cardiology.

Is it time to relitigate SGLT2 Inhibitor dose for heart failure?

J. Howlett, 2023, The Canadian journal of cardiology.

Hypertension Canada's 2016 CHEP Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension

Lawrence A Leiter, P. McFarlane, A. Logan, 2016 .

Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF

Akshay S. Desai, P. Ponikowski, S. Solomon, 2021, European journal of heart failure.

Thrombus formation on an atrial septal defect closure device.

J. Howlett, C. Kells, K. Hirsch, 2005, The Canadian journal of cardiology.

The Canadian Heart Health Strategy and Action Plan: Cardiac rehabilitation as an exemplar of chronic disease management.

M. Fortin, M. Bayley, H. Arthur, 2010, The Canadian journal of cardiology.

Determinants of early readmission after hospitalization for heart failure.

C. Eastwood, F. McAlister, H. Quan, 2014, The Canadian journal of cardiology.

The effect of comorbidity on the competing risk of sudden and nonsudden death in an ambulatory heart failure population.

B. Clarke, J. Sapp, J. Howlett, 2011, The Canadian journal of cardiology.

Right Ventricular Systolic Pressure Trajectory as a Predictor of Hospitalization and Mortality in Patients With Chronic Heart Failure

F. McAlister, N. Fine, J. Ezekowitz, 2023, CJC open.

Changes in the Minnesota Living With Heart Failure Questionnaire Score and Clinical Outcomes in a Large Contemporary Population of Ambulatory Heart Failure Patients in the Canadian Heart Failure Network

G. Marchiori, A. Kaan, A. Ignaszewski, 2012 .

Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study

A. Ignaszewski, H. Ross, M. White, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Obstructive sleep apnea and heart failure-an often over-looked association

J. Howlett, N. Sharma, Rajat Sharma, 2015 .

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk

F. McAlister, N. Fine, J. Ezekowitz, 2022, ESC Heart Failure.

Cardiovascular Fitness and Adaptations to Aerobic Training after Stroke

M. MacKay-Lyons, R. Macko, J. Howlett, 2006 .

Outcomes in patients undergoing cardiac retransplantation: A propensity matched cohort analysis of the UNOS Registry.

K. Khush, B. Clarke, J. Teuteberg, 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

A prospective evaluation of the established criteria for heart failure with preserved ejection fraction using the Alberta HEART cohort

I. Belenkie, F. McAlister, J. Dyck, 2017, ESC heart failure.

STICH3C: Rationale and Study Protocol

Jeroen J. Bax, A. Kiss, J. Healey, 2023, Circulation. Cardiovascular interventions.

Ten year survival by NYHA functional class in heart failure outpatients referred to specialized multidisciplinary heart failure clinics 1999 to 2011

A. Kaan, A. Ignaszewski, Peter P. Liu, 2013 .

Change of Health‐Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure

J. Spertus, F. McAlister, J. Dyck, 2020, Journal of the American Heart Association.

Initiation of ivabradine in cardiogenic shock

J. Howlett, N. Sharma, Michael H Chiu, 2019, ESC Heart Failure.

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey

K. Dickstein, J. Howlett, A. Fuat, 2017, ESC heart failure.